BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19458171)

  • 21. The role of Vpr in HIV-1 pathogenesis.
    Andersen JL; Planelles V
    Curr HIV Res; 2005 Jan; 3(1):43-51. PubMed ID: 15638722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Mechanism of HIV-1 Vpr for Binding to Importin-α.
    Miyatake H; Sanjoh A; Murakami T; Murakami H; Matsuda G; Hagiwara K; Yokoyama M; Sato H; Miyamoto Y; Dohmae N; Aida Y
    J Mol Biol; 2016 Jul; 428(13):2744-57. PubMed ID: 27181198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
    Kino T; Pavlakis GN
    DNA Cell Biol; 2004 Apr; 23(4):193-205. PubMed ID: 15142377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization.
    Ferrucci A; Nonnemacher MR; Wigdahl B
    Virol J; 2011 Aug; 8():397. PubMed ID: 21831263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function relationship of Vpr: biological implications.
    Morellet N; Roques BP; Bouaziz S
    Curr HIV Res; 2009 Mar; 7(2):184-210. PubMed ID: 19275588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
    Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest.
    Blondot ML; Dragin L; Lahouassa H; Margottin-Goguet F
    Retrovirology; 2014 Dec; 11():117. PubMed ID: 25496524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyploidy and Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes in Renal Tubule Epithelial Cells.
    Payne EH; Ramalingam D; Fox DT; Klotman ME
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1.
    Zhang S; Pointer D; Singer G; Feng Y; Park K; Zhao LJ
    Gene; 1998 Jun; 212(2):157-66. PubMed ID: 9611258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Vpr protein from HIV-1: distinct roles along the viral life cycle.
    Le Rouzic E; Benichou S
    Retrovirology; 2005 Feb; 2():11. PubMed ID: 15725353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
    Sauter D; Kirchhoff F
    Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Vpr increases HCV replication through VprBP in cell culture.
    Yan Y; Huang F; Yuan T; Sun B; Yang R
    Virus Res; 2016 Sep; 223():153-60. PubMed ID: 27460548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Vpr: a closer look at the multifunctional protein from the structural perspective.
    Pandey RC; Datta D; Mukerjee R; Srinivasan A; Mahalingam S; Sawaya BE
    Curr HIV Res; 2009 Mar; 7(2):114-28. PubMed ID: 19275580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.
    Kogan M; Rappaport J
    Retrovirology; 2011 Apr; 8():25. PubMed ID: 21489275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accessories to the crime: recent advances in HIV accessory protein biology.
    Gramberg T; Sunseri N; Landau NR
    Curr HIV/AIDS Rep; 2009 Feb; 6(1):36-42. PubMed ID: 19149995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 Vpr Induces Degradation of Gelsolin, a Myeloid Cell-Specific Host Factor That Reduces Viral Infectivity by Inhibiting the Expression and Packaging of the HIV-1 Env Glycoprotein.
    Fabryova H; Kao S; Sukegawa S; Miyagi E; Taylor L; Ferhadian D; Saito H; Schaal H; Hillebrand F; Strebel K
    mBio; 2023 Feb; 14(1):e0297322. PubMed ID: 36602307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus vpr gene encodes a virion-associated protein.
    Yuan X; Matsuda Z; Matsuda M; Essex M; Lee TH
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1265-71. PubMed ID: 2150318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
    Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
    Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.
    González ME
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.